Cost-effectiveness of cognitive behaviour therapy for patients with chronic fatigue syndrome

QJM: An International Journal of Medicine

Volumn 97, Issue 3, 2004, Pages 153-161

  Severens, J L ^a,b   Prins, J B ^a   van der Wilt, G J ^a   van der Meer, J W M ^a   Bleijenberg, G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIOR THERAPY; CHRONIC FATIGUE SYNDROME; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; FOLLOW UP; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SUPPORT GROUP;

EID: 1542709225     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hch029     Document Type: Article

References (22)

1. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes, 2nd edn. Oxford, Oxford Medical Publications, 1997.
2. Berger M. Design of prospective cost-effectiveness clinical trials: The critical role of the comparator group. Drug Inform J 1995; 29:1415-20.
3. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A, et al. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Intern Med 1994; 121:953-9.
4. Reid S, Chalder T, Cleare A, Hotopf M, Wessely S. Chronic fatigue syndrome. Br Med J 2000; 320:292-6.
5. Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome and fibromyalgia: Disability and health care use. Med Care 1996; 34:924-30.
6. Sharpe M, Hawton K, Simkin S, Suraway C, Hackman A, Klimes I, et al. Cognitive behaviour therapy for the chronic fatigue syndrome: A randomised controlled trial. Br Med J 1996; 312:22-6.
7. Deale A, Chalder T, Marks I, Wessely S. Cognitive behaviour therapy for chronic fatigue syndrome: A randomized controlled trial. Am J Psychiatry 1997; 154:408-14.
8. Prins JB, Bleijenberg G, Bazelmans E, Elving LD, De Boo TD, Severens JL, et al. Cognitive behaviour therapy for chronic fatigue syndrome: A multicentre randomised controlled trial. Lancet 2001; 357:841-7.
9. Beurskens AJHM, Bültmann U, Kart IJ, Vercoulen JHMM, Bleijenberg G, Swaen GMH. Fatigue amongst working people: Validity of a questionnaire measure. Occup Environ Med 2000; 57:353-7.
10. Bültmann U, De Vries M, Beurskens AJHM, Bleijenberg G, Vercoulen JHMM, Kart IJ. Measurement of prolonged fatigue in the working population: Determination of a cut-off point for the Checklist Individual Strength. J Occup Health Psych 2000; 5:411-16.
11. Guyatt GH, Feeny DH, Patrick DL. Measuring health related quality of life. Ann Intern Med 1993; 118:622-9.
12. Dolan P. Modeling valuations for EuroQol health states. Medical Care 1997; 35:10975-108.
13. Rutten FFH, Van Ineveld BM, Van Ommen R, Van Hout BA, Huijsman R. Cost analysis in health care research; practical guidelines. Utrecht, Uitgeverij Jan van Arkel (in Dutch), 1993.
14. Rutten-van Mölken MPMH, Van Doorslaer EKA, Van Vliet RCJA. Statistical analysis of cost outcomes in a randomized controlled clinical trial. Health Economics 1994; 3:333-45.
15. Briggs AH, Sculpher M, Buxton MJ. Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis. Health Economics 1994; 3:95-104.
16. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation. Health Economics 1997; 6:327-40.
17. Briggs AH, Gray AM. Handling uncertainty when performing economic evaluation of health care interventions. Health Technology Assessment 1999; 3:1-134.
18. Whiting P, Bagnall A, Sowden AJ, Cornell JE, Mulrow CD, Raminez G. Interventions for the treatment and management of. chronic fatgue syndrome; a systematic review. JAMA 2001; 286:1360-8.
19. Goossens MEJB, Rutten-van Mölken MPMH, Vlaeyen JWS, Van der Linden SMJP. The cost diary: A method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000; 53:688-95.
20. Thompson D, Hylan TR, McMullan W, Romeis ME, Buesching D, Oster G. Predictors of a medical-offset effect among patients, receiving antidepressant therapy. Am J Psychiatry 1998; 155:824-827.
21. Lloyd AR, Pender H. The economic impact of chronic fatigue syndrome. Med J Aust 1992; 157:599-601.
22. Russo J, Katon W, Clark M, Kith P, Sintay M, Buchwald D. Longitudinal changes associaied with improvement in chronic fatigue patients. J Psychosom Res 1998; 45:67-76.